Global Intravenous-to-Subcutaneous Drug Sales Market Report 2017

December 2017 | 107 pages | ID: GDD54317F8DEN
QYResearch

Abstracts

In this report, the global Intravenous-to-Subcutaneous Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Intravenous-to-Subcutaneous Drug for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Intravenous-to-Subcutaneous Drug market competition by top manufacturers/players, with Intravenous-to-Subcutaneous Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• GSK
• Merck

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Prescription
• OCT

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Intravenous-to-Subcutaneous Drug Sales Market Report 2017

1 INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
1.2 Classification of Intravenous-to-Subcutaneous Drug by Product Category
  1.2.1 Global Intravenous-to-Subcutaneous Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Intravenous-to-Subcutaneous Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Prescription
  1.2.4 OCT
1.3 Global Intravenous-to-Subcutaneous Drug Market by Application/End Users
  1.3.1 Global Intravenous-to-Subcutaneous Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 Global Intravenous-to-Subcutaneous Drug Market by Region
  1.4.1 Global Intravenous-to-Subcutaneous Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
  1.4.3 China Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
  1.4.4 Europe Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
  1.4.5 Japan Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
  1.4.7 India Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drug (2012-2022)
  1.5.1 Global Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Intravenous-to-Subcutaneous Drug Market Competition by Players/Suppliers
  2.1.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Intravenous-to-Subcutaneous Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Intravenous-to-Subcutaneous Drug (Volume and Value) by Type
  2.2.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Intravenous-to-Subcutaneous Drug (Volume and Value) by Region
  2.3.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share by Region (2012-2017)
  2.3.2 Global Intravenous-to-Subcutaneous Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Intravenous-to-Subcutaneous Drug (Volume) by Application

3 UNITED STATES INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  3.1.1 United States Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
3.2 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
3.3 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
3.4 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

4 CHINA INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  4.1.1 China Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
4.2 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
4.3 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
4.4 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

5 EUROPE INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  5.1.1 Europe Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
5.2 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
5.3 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
5.4 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

6 JAPAN INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  6.1.1 Japan Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
6.2 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
6.3 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
6.4 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

7 SOUTHEAST ASIA INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

8 INDIA INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  8.1.1 India Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
8.2 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
8.3 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
8.4 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

9 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Novartis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novartis Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 GSK
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 GSK Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Merck
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Merck Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview

10 INTRAVENOUS-TO-SUBCUTANEOUS DRUG MAUFACTURING COST ANALYSIS

10.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
10.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKET FORECAST (2017-2022)

14.1 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Intravenous-to-Subcutaneous Drug Price and Trend Forecast (2017-2022)
14.2 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Intravenous-to-Subcutaneous Drug Sales Forecast by Type (2017-2022)
  14.3.2 Global Intravenous-to-Subcutaneous Drug Revenue Forecast by Type (2017-2022)
  14.3.3 Global Intravenous-to-Subcutaneous Drug Price Forecast by Type (2017-2022)
14.4 Global Intravenous-to-Subcutaneous Drug Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Intravenous-to-Subcutaneous Drug
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Prescription Product Picture
Figure OCT Product Picture
Figure Global Intravenous-to-Subcutaneous Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Intravenous-to-Subcutaneous Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Global Intravenous-to-Subcutaneous Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Intravenous-to-Subcutaneous Drug Sales Share by Players/Suppliers
Figure 2017 Intravenous-to-Subcutaneous Drug Sales Share by Players/Suppliers
Figure Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Intravenous-to-Subcutaneous Drug Revenue Share by Players
Table 2017 Global Intravenous-to-Subcutaneous Drug Revenue Share by Players
Table Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Sales Growth Rate by Type (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Growth Rate by Type (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Region (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Sales Growth Rate by Region in 2016
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Region (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Growth Rate by Region in 2016
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Region (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Market Share by Region in 2016
Table Global Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Intravenous-to-Subcutaneous Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Application (2012-2017)
Figure Global Intravenous-to-Subcutaneous Drug Sales Market Share by Application (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table United States Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table United States Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Figure China Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table China Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table China Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Figure Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Figure Japan Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Figure India Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players (2012-2017)
Figure India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Players in 2016
Table India Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (2012-2017)
Figure India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type in 2016
Table India Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application (2012-2017)
Figure India Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Application in 2016
Table Novartis Basic Information List
Table Novartis Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Intravenous-to-Subcutaneous Drug Sales Growth Rate (2012-2017)
Figure Novartis Intravenous-to-Subcutaneous Drug Sales Global Market Share (2012-2017
Figure Novartis Intravenous-to-Subcutaneous Drug Revenue Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Intravenous-to-Subcutaneous Drug Sales Growth Rate (2012-2017)
Figure GSK Intravenous-to-Subcutaneous Drug Sales Global Market Share (2012-2017
Figure GSK Intravenous-to-Subcutaneous Drug Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Intravenous-to-Subcutaneous Drug Sales Growth Rate (2012-2017)
Figure Merck Intravenous-to-Subcutaneous Drug Sales Global Market Share (2012-2017
Figure Merck Intravenous-to-Subcutaneous Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous-to-Subcutaneous Drug
Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
Figure Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
Table Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Players in 2016
Table Major Buyers of Intravenous-to-Subcutaneous Drug
Table Distributors/Traders List
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Intravenous-to-Subcutaneous Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources